Medicines for severe asthma and growth hormone deficiency listed on the PBS

The Liberal National Government will list new medicines for severe asthma, and severe growth hormone deficiency on the Pharmaceutical Benefits Scheme (PBS), saving patients up to $21,000 a year.   From today Fasenra® (benralizumab), a new treatment option for patients with uncontrolled severe eosinophilic asthma, will be available on the PBS.   Around 670 patients…